Bharat Biotech's Covaxin human trial begins at PGI Rohtak


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ Bharat Biotech's Covaxin human trial begins at PGI Rohtak
Seven anti Corona vaccines being developed in India

The human trial of Bharat Biotech's anti-Covid-19 vaccine Covaxin began at Rohtak's Post-Graduate Institute of Medical Sciences on Friday, Haryana Health Minister Anil Vij tweeted.

"Human trial with Corona vaccine (COVAXIN) of Bharat Biotech started at PGI Rohtak today," Vij, who is also the Home and Science & Technology minister said.

"Three subjects were enrolled today. All have tolerated the vaccine very well. There were no adverse effects," Vij further said in his tweet.

Bharat Biotech got the country's drug regulator's approval to start clinical trials of its anti-Corona vaccine Covaxin recently.There are over seven anti-corona vaccines at various stages of development in the country with two of them having received the drug regulator's go-ahead to start the human clinical trials of their vaccines.

Earlier this month, Zydus had said it has received approval from authorities to start human trials for its anti-COVID-19 vaccine.India has become one of the frontrunners in the global effort to develop a vaccine for the containment of Covid-19 pandemic. Government agencies have stepped up collaboration with private partners to fastrack the approval process needed for development of a potential Covid vaccine. Bharat Biotech and Zydus Cadilla started the human clinical trials of their potential vaccines after getting the approvals from the Central Drug Standard Control Organization.

According to reports,  India has fast tracked its efforts for the development of Covid-19 vaccine which are under human clinical trials stage. India is considered a pharmacy of the world and 60 per cent of the vaccine at world level is supplied by India. ICMR and Bharat Biotech have joined hands for the development of a potential Covid-19 vaccine called 'Covaxin' whereas the Department of Biotechnology has partially funded the development of Zydus's vaccine ZyCov-D. Zydus has set the target to complete the phase-I and II human clinical trial in the next three months. However, the final outcome will depend on the cooperation of all clinical sites involved in this project.

Another top Indian pharma company Serum Institute of India has bagged a contract with British drugmaker AstraZeneca to supply one billion doses of Oxford University's potential COVID-19 vaccine. This vaccine is currently at the most advanced stage at the world level. The World Health Organization has expressed hope that the Covid vaccine will come by next year.

Tags : #BharatBiotech #Covaxin #HumanTrial #PGIRohtak #SerumInstitute #Astrazeneca #ZydusCadila #CoronaVaccineNews #PharmaNewsUpdate #OxfordUniversity

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026